We are live on ! Find out more
EHWM

Eads & Heald Wealth Management Portfolio holdings

AUM $201M
1-Year Est. Return 21.29%
This Fund
S&P 500
This Quarter Est. Return
+3.11%
1 Year Est. Return
+21.29%
3 Year Est. Return
+70.18%
5 Year Est. Return
+104.01%
10 Year Est. Return
+364.64%
AUM
$156M
AUM Growth
+$749K
Cap. Flow
-$3.31M
Cap. Flow %
-2.12%
Top 10 Hldgs %
14.98%
Holding
135
New
5
Increased
32
Reduced
87
Closed
5

Top Buys

Rank Stock Value
1
FL
Foot Locker
FL
+$855K
2
RHT
Red Hat Inc
RHT
+$676K
3
BMS
Bemis
BMS
+$625K
4
GWW icon
W.W. Grainger
GWW
+$480K
5
AVY icon
Avery Dennison
AVY
+$352K

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$675K
2
VAL
Valspar
VAL
+$430K
3
DOV icon
Dover
DOV
+$411K
4
TGT icon
Target
TGT
+$371K
5
SRCL
Stericycle Inc
SRCL
+$348K

Sector Composition

Rank Sector Weight
1 Healthcare 16.66%
2 Industrials 14.66%
3 Technology 13.45%
4 Consumer Discretionary 12.88%
5 Consumer Staples 12.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
101
Kimberly-Clark
KMB
$37.5B
$506K 0.32%
3,919
+25
+0.6% +$3.25K
FDX icon
102
FedEx
FDX
$74B
$493K 0.32%
2,269
-160
-7% -$31.6K
HAL icon
103
Halliburton
HAL
$26.1B
$489K 0.31%
11,457
+80
+0.7% +$3.67K
MAR icon
104
Marriott International
MAR
$101B
$486K 0.31%
4,841
-235
-5% -$23.5K
DGX icon
105
Quest Diagnostics
DGX
$26B
$484K 0.31%
4,355
+1,995
+85% +$211K
MKC icon
106
McCormick & Company Non-Voting
MKC
$13.9B
$472K 0.3%
9,680
DE icon
107
Deere & Co
DE
$173B
$449K 0.29%
3,629
-69
-2% -$8.1K
PX
108
DELISTED
Praxair Inc
PX
$442K 0.28%
3,338
-442
-12% -$56.7K
ADI icon
109
Analog Devices
ADI
$178B
$414K 0.27%
5,321
-145
-3% -$11.5K
BUD icon
110
AB InBev
BUD
$161B
$406K 0.26%
3,679
-58
-2% -$6.64K
STZ icon
111
Constellation Brands
STZ
$22.5B
$393K 0.25%
2,029
-19
-0.9% -$3.38K
FDS icon
112
Factset
FDS
$10.1B
$392K 0.25%
2,358
+20
+0.9% +$3.27K
AVY icon
113
Avery Dennison
AVY
$12.9B
$371K 0.24%
+4,200
New +$352K
OMC icon
114
Omnicom Group
OMC
$24.6B
$287K 0.18%
+3,467
New +$289K
VMC icon
115
Vulcan Materials
VMC
$37.4B
$286K 0.18%
2,257
+17
+0.8% +$2.13K
BIIB icon
116
Biogen
BIIB
$30.4B
$276K 0.18%
1,016
-165
-14% -$43.6K
HSIC icon
117
Henry Schein
HSIC
$9.76B
$274K 0.18%
3,817
+20
+0.5% +$1.39K
AGN
118
DELISTED
Allergan plc
AGN
$271K 0.17%
1,114
-3
-0.3% -$705
GSK icon
119
GSK
GSK
$108B
$270K 0.17%
5,017
-2
-0% -$107
TOL icon
120
Toll Brothers
TOL
$14.5B
$265K 0.17%
6,705
-40
-0.6% -$1.49K
APC
121
DELISTED
Anadarko Petroleum
APC
$225K 0.14%
4,962
-305
-6% -$16.2K
EFX icon
122
Equifax
EFX
$22B
$215K 0.14%
1,565
-50
-3% -$6.86K
ITT icon
123
ITT
ITT
$17.8B
$215K 0.14%
5,339
-1,090
-17% -$43.5K
HSY icon
124
Hershey
HSY
$37.2B
$209K 0.13%
1,946
GM icon
125
General Motors
GM
$81.7B
$206K 0.13%
5,910
+165
+3% +$5.6K

Similar funds

Eads & Heald Wealth Management's Q2 2017 Portfolio in Review

As of Q2 2017, Eads & Heald Wealth Management held 135 positions worth $156M, up 0.48% from $155M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Eads & Heald Wealth Management's Q2 2017 filing shows 5 new, 32 increased, 87 reduced and 5 closed positions. Its largest new stake was Foot Locker: 13,184 shares worth $650K. The largest sale was CR Bard Inc., an estimated $675K.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.

  • Eads & Heald Wealth Management's largest Q2 2017 buy was Foot Locker: 13,184 shares worth $650K.
  • Eads & Heald Wealth Management added most to Bemis in Q2 2017, an estimated $625K increase.
  • Eads & Heald Wealth Management's biggest Q2 2017 reduction was CR Bard Inc., cutting an estimated $675K.
  • Eads & Heald Wealth Management fully exited Valspar in Q2 2017, selling an estimated $430K.
  • Eads & Heald Wealth Management's ten largest holdings make up 15% of its $156M portfolio in Q2 2017.
  • Eads & Heald Wealth Management opened 5 new positions and closed 5 in Q2 2017.
  • Eads & Heald Wealth Management's portfolio value rose 0.48% quarter-over-quarter to $156M.

Based on Eads & Heald Wealth Management's 13F filing for Q2 2017, filed 31 Jul 2017.